<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37809087</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Association between immunoglobulin G N-glycosylation and lupus nephritis in female patients with systemic lupus erythematosus: a case-control study.</ArticleTitle><Pagination><StartPage>1257906</StartPage><MedlinePgn>1257906</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1257906</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1257906</ELocationID><Abstract><AbstractText Label="BACKGROUND">Lupus nephritis (LN) is a crucial complication of systemic lupus erythematosus (SLE) and has important clinical implications in guiding treatment. N-glycosylation of immunoglobulin G (IgG) plays a key role in the development of SLE by affecting the balance of anti-inflammatory and proinflammatory responses. This study aimed to evaluate the performance of IgG N-glycosylation for diagnosing LN in a sample of female SLE patients.</AbstractText><AbstractText Label="METHODS">This case-control study recruited 188 women with SLE, including 94 patients with LN and 94 age-matched patients without LN. The profiles of plasma IgG N-glycans were detected by hydrophilic interaction chromatography with ultra-performance liquid chromatography (HILIC-UPLC). A multivariate logistic regression model was used to explore the associations between IgG N-glycans and LN. A diagnostic model was developed using the significant glycans as well as demographic factors. The performance of IgG N-glycans in the diagnosis of LN was evaluated by receiver operating characteristic (ROC) curve analysis, and the area under the curve (AUC) and its 95% confidence interval (CI) were calculated.</AbstractText><AbstractText Label="RESULTS">There were significant differences in 9 initial glycans (GP2, GP4, GP6, GP8, GP10, GP14, GP16, GP18 and GP23) between women with SLE with and without LN (<i>P</i> &lt; 0.05). The levels of sialylated, galactosylated and fucosylated glycans were significantly lower in the LN patients than in the control group, while bisected N-acetylglucosamine (GlcNAc) glycans were increased in LN patients (<i>P</i> &lt; 0.05). GP8, GP10, GP18, and anemia were included in our diagnostic model, which performed well in differentiating female SLE patients with LN from those without LN (AUC = 0.792, 95% CI: 0.727 to 0.858).</AbstractText><AbstractText Label="CONCLUSION">Our findings indicate that decreased sialylation, galactosylation, and core fucosylation and increased bisecting GlcNAc might play a role in the development of LN by upregulating the proinflammatory response of IgG. IgG N-glycans can serve as potential biomarkers to differentiate individuals with LN among SLE patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Lu, Wang, Wang, Li, Zhao, Shi, Zhang, Wang, Wang, Ji, Hou and Li.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Xinxia</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Public Health, Shandong First Medical University &amp; Shandong Academy of Medical Sciences, Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Liangao</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Public Health, Shandong First Medical University &amp; Shandong Academy of Medical Sciences, Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Meng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Public Health, Shandong First Medical University &amp; Shandong Academy of Medical Sciences, Jinan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jinshan District Center for Disease Control and Prevention, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yuejin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Shandong Institute of Parasitic Diseases, Shandong First Medical University &amp; Shandong Academy of Medical Sciences, Jining, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Qinqin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Geriatric Cognitive Medicine, The Affiliated Taian City Central Hospital of Qingdao University, Taian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Yanjun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Liaocheng People's Hospital, Liao'cheng, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yujing</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Public Health, Shandong First Medical University &amp; Shandong Academy of Medical Sciences, Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yingjie</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Public Health, Shandong First Medical University &amp; Shandong Academy of Medical Sciences, Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>School of Public Health, Shandong First Medical University &amp; Shandong Academy of Medical Sciences, Jinan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Precision Health, School of Medical and Health Sciences, Edith Cowan University, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Long</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Public Health, Shandong First Medical University &amp; Shandong Academy of Medical Sciences, Jinan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Sports Medicine and Rehabilitation, Shandong First Medical University &amp; Shandong Academy of Medical Sciences, Tai'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Haifeng</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Public Health, Shandong First Medical University &amp; Shandong Academy of Medical Sciences, Jinan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Gastroenterology, The Second Affiliated Hospital of Shandong First Medical University, Tai'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Dong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Public Health, Shandong First Medical University &amp; Shandong Academy of Medical Sciences, Jinan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research Center, The Second Affiliated Hospital of Shandong First Medical University, Tai'an, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011134">Polysaccharides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006031" MajorTopicYN="N">Glycosylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011134" MajorTopicYN="N">Polysaccharides</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">N-glycosylation</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">immunoglobulin G</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">lupus nephritis</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>9</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>9</Day><Hour>5</Hour><Minute>51</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37809087</ArticleId><ArticleId IdType="pmc">PMC10552529</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1257906</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Iwamoto T, Niewold TB. Genetics of human lupus nephritis. Clin Immunol (2017) 185:32&#x2013;9. doi: 10.1016/j.clim.2016.09.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2016.09.012</ArticleId><ArticleId IdType="pmc">PMC5373939</ArticleId><ArticleId IdType="pubmed">27693588</ArticleId></ArticleIdList></Reference><Reference><Citation>Almaani S, Meara A, Rovin BH. Update on lupus nephritis. Clin J Am Soc Nephrol (2017) 12(5):825&#x2013;35. doi: 10.2215/CJN.05780616</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.05780616</ArticleId><ArticleId IdType="pmc">PMC5477208</ArticleId><ArticleId IdType="pubmed">27821390</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahajan A, Amelio J, Gairy K, Kaur G, Levy RA, Roth D, et al. . Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression. Lupus (2020) 29(9):1011&#x2013;20. doi: 10.1177/0961203320932219</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203320932219</ArticleId><ArticleId IdType="pmc">PMC7425376</ArticleId><ArticleId IdType="pubmed">32571142</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoub I, Wolf BJ, Geng L, Song H, Khatiwada A, Tsao BP, et al. . Prediction models of treatment response in lupus nephritis. Kidney Int (2022) 101(2):379&#x2013;89. doi: 10.1016/j.kint.2021.11.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2021.11.014</ArticleId><ArticleId IdType="pmc">PMC8792241</ArticleId><ArticleId IdType="pubmed">34871620</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y, Yang X, Zhang X, An Z. Analysis of expression levels of IL-17 and IL-34 and influencing factors for prognosis in patients with lupus nephritis. Exp Ther Med (2019) 17(3):2279&#x2013;83. doi: 10.3892/etm.2019.7168</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2019.7168</ArticleId><ArticleId IdType="pmc">PMC6364195</ArticleId><ArticleId IdType="pubmed">30783486</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap D, Chan TM. B cell abnormalities in systemic lupus erythematosus and lupus nephritis-role in pathogenesis and effect of immunosuppressive treatments. Int J Mol Sci (2019) 20(24):6231. doi: 10.3390/ijms20246231</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20246231</ArticleId><ArticleId IdType="pmc">PMC6940927</ArticleId><ArticleId IdType="pubmed">31835612</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang A, Clark MR, Ko K. Cellular aspects of the pathogenesis of lupus nephritis. Curr Opin Rheumatol (2021) 33(2):197&#x2013;204. doi: 10.1097/BOR.0000000000000777</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000777</ArticleId><ArticleId IdType="pmc">PMC7905798</ArticleId><ArticleId IdType="pubmed">33394604</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhargava R, Li H, Tsokos GC. Pathogenesis of lupus nephritis: the contribution of immune and kidney resident cells. Curr Opin Rheumatol (2023) 35(2):107&#x2013;16. doi: 10.1097/BOR.0000000000000887</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000887</ArticleId><ArticleId IdType="pubmed">35797522</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhat P, Radhakrishnan J. B lymphocytes and lupus nephritis: new insights into pathogenesis and targeted therapies. Kidney Int (2008) 73(3):261&#x2013;8. doi: 10.1038/sj.ki.5002663</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ki.5002663</ArticleId><ArticleId IdType="pubmed">18004299</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao M, Gao C, Zhang C, Di X, Liang W, Sun W, et al. . Identification of molecular markers associated with the pathophysiology and treatment of lupus nephritis based on integrated transcriptome analysis. Front Genet (2020) 11:583629. doi: 10.3389/fgene.2020.583629</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2020.583629</ArticleId><ArticleId IdType="pmc">PMC7770169</ArticleId><ArticleId IdType="pubmed">33384713</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Q, Wu C, Dai M, Wang S, Xu J, Dai L, et al. . Leflunomide versus azathioprine for maintenance therapy of lupus nephritis: a prospective, multicentre, randomised trial and long-term follow-up. Ann Rheum Dis (2022) 81(11):1549&#x2013;55. doi: 10.1136/ard-2022-222486</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard-2022-222486</ArticleId><ArticleId IdType="pmc">PMC9606489</ArticleId><ArticleId IdType="pubmed">35788493</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudspeth K, Wang S, Wang J, Rahman S, Smith MA, Casey KA, et al. . Natural killer cell expression of Ki67 is associated with elevated serum IL-15, disease activity and nephritis in systemic lupus erythematosus. Clin Exp Immunol (2019) 196(2):226&#x2013;36. doi: 10.1111/cei.13263</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13263</ArticleId><ArticleId IdType="pmc">PMC6468178</ArticleId><ArticleId IdType="pubmed">30693467</ArticleId></ArticleIdList></Reference><Reference><Citation>Radovani B, Vuckovic F, Maggioni AP, Ferrannini E, Lauc G, Gudelj I. IgG N-glycosylation is altered in coronary artery disease. Biomolecules (2023) 13(2):375. doi: 10.3390/biom13020375</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom13020375</ArticleId><ArticleId IdType="pmc">PMC9953309</ArticleId><ArticleId IdType="pubmed">36830744</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan H, Wu Z, Zhang H, Zhang J, Liu Y, Li Z, et al. . Identification and validation of IgG N-glycosylation biomarkers of esophageal carcinoma. Front Immunol (2023) 14:981861. doi: 10.3389/fimmu.2023.981861</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.981861</ArticleId><ArticleId IdType="pmc">PMC10043232</ArticleId><ArticleId IdType="pubmed">36999031</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh SS, Heijmans R, Meulen C, Lieverse AG, Gornik O, Sijbrands E, et al. . Association of the IgG N-glycome with the course of kidney function in type 2 diabetes. BMJ Open Diabetes Res Care (2020) 8(1):e001026. doi: 10.1136/bmjdrc-2019-001026</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjdrc-2019-001026</ArticleId><ArticleId IdType="pmc">PMC7213753</ArticleId><ArticleId IdType="pubmed">32349995</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauc G, Huffman JE, Pucic M, Zgaga L, Adamczyk B, Muzinic A, et al. . Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers. PloS Genet (2013) 9(1):e1003225. doi: 10.1371/journal.pgen.1003225</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1003225</ArticleId><ArticleId IdType="pmc">PMC3561084</ArticleId><ArticleId IdType="pubmed">23382691</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X, Motta F, Selmi C, Ridgway WM, Gershwin ME, Zhang W. Antibody glycosylation in autoimmune diseases. Autoimmun Rev (2021) 20(5):102804. doi: 10.1016/j.autrev.2021.102804</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102804</ArticleId><ArticleId IdType="pmc">PMC8058319</ArticleId><ArticleId IdType="pubmed">33727152</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu P, Wang X, Dun A, Li Y, Li H, Wang L, et al. . High-throughput profiling of serological immunoglobulin g n-glycome as a noninvasive biomarker of gastrointestinal cancers. Engineering (2023). doi: 10.1016/j.eng.2023.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eng.2023.02.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou H, Yang H, Liu P, Huang C, Wang M, Li Y, et al. . Profile of immunoglobulin G N-glycome in COVID-19 patients: A case-control study. Front Immunol (2021) 12:748566. doi: 10.3389/fimmu.2021.748566</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.748566</ArticleId><ArticleId IdType="pmc">PMC8495247</ArticleId><ArticleId IdType="pubmed">34630427</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Shi F, Wang G, Lv J, Zhang H, Jin H, et al. . Expression profile of immunoglobulin G glycosylation in children with epilepsy in han nationality. Front Mol Neurosci (2022) 15:843897. doi: 10.3389/fnmol.2022.843897</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2022.843897</ArticleId><ArticleId IdType="pmc">PMC9283856</ArticleId><ArticleId IdType="pubmed">35845609</ArticleId></ArticleIdList></Reference><Reference><Citation>Varadi C, Hajdu V, Farkas F, Gilanyi I, Olah C, Viskolcz B. The analysis of human serum N-glycosylation in patients with primary and metastatic brain tumors. Life (Basel) (2021) 11(1):29. doi: 10.3390/life11010029</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life11010029</ArticleId><ArticleId IdType="pmc">PMC7825111</ArticleId><ArticleId IdType="pubmed">33418875</ArticleId></ArticleIdList></Reference><Reference><Citation>Haslund-Gourley BS, Wigdahl B, Comunale MA. IgG N-glycan signatures as potential diagnostic and prognostic biomarkers. Diagn (Basel) (2023) 13(6):1016. doi: 10.3390/diagnostics13061016</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13061016</ArticleId><ArticleId IdType="pmc">PMC10047871</ArticleId><ArticleId IdType="pubmed">36980324</ArticleId></ArticleIdList></Reference><Reference><Citation>Gyebrovszki B, Acs A, Szabo D, Auer F, Novozanszki S, Rojkovich B, et al. . The role of igG fc region N-glycosylation in the pathomechanism of rheumatoid arthritis. Int J Mol Sci (2022) 23(10):5828. doi: 10.3390/ijms23105828</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23105828</ArticleId><ArticleId IdType="pmc">PMC9146365</ArticleId><ArticleId IdType="pubmed">35628640</ArticleId></ArticleIdList></Reference><Reference><Citation>Siekman SL, Pongracz T, Wang W, Nouta J, Kremsner PG, Da SP, et al. . The IgG glycome of SARS-CoV-2 infected individuals reflects disease course and severity. Front Immunol (2022) 13:993354. doi: 10.3389/fimmu.2022.993354</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.993354</ArticleId><ArticleId IdType="pmc">PMC9641981</ArticleId><ArticleId IdType="pubmed">36389824</ArticleId></ArticleIdList></Reference><Reference><Citation>Stambuk J, Vuckovic F, Habazin S, Hanic M, Novokmet M, Nikolaus S, et al. . Distinct longitudinal changes in immunoglobulin G N-glycosylation associate with therapy response in chronic inflammatory diseases. Int J Mol Sci (2022) 23(15). doi: 10.3390/ijms23158473</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23158473</ArticleId><ArticleId IdType="pmc">PMC9368836</ArticleId><ArticleId IdType="pubmed">35955616</ArticleId></ArticleIdList></Reference><Reference><Citation>Sjowall C, Zapf J, von Lohneysen S, Magorivska I, Biermann M, Janko C, et al. . Altered glycosylation of complexed native IgG molecules is associated with disease activity of systemic lupus erythematosus. Lupus (2015) 24(6):569&#x2013;81. doi: 10.1177/0961203314558861</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203314558861</ArticleId><ArticleId IdType="pubmed">25389233</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Tang Z, Shi Y, Ji L, Chen X, Chen Y, et al. . Association between gamma-glutamyl transferase, total bilirubin and systemic lupus erythematosus in Chinese women. Front Immunol (2021) 12:682400. doi: 10.3389/fimmu.2021.682400</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.682400</ArticleId><ArticleId IdType="pmc">PMC8277571</ArticleId><ArticleId IdType="pubmed">34276670</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. . European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis (2019) 78(9):1151&#x2013;9. doi: 10.1136/annrheumdis-2018-214819</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2018-214819</ArticleId><ArticleId IdType="pubmed">31383717</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Yang NS, Lu J, Cao H, Du R, Zhang W, et al. . Recommendations for the diagnosis and management of lupus nephritis in China. Zhonghua Nei Ke Za Zhi (2021) 60(9):784&#x2013;90. doi: 10.3760/cma.j.cn112138-20210609-00410</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.cn112138-20210609-00410</ArticleId><ArticleId IdType="pubmed">34445813</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Chen X, Tang Z, Zhang W, Hou H, Sun X, et al. . Association between immunoglobulin G N-glycosylation and vascular cognitive impairment in a sample with atherosclerosis: A case-control study. Front Aging Neurosci (2022) 14:823468. doi: 10.3389/fnagi.2022.823468</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.823468</ArticleId><ArticleId IdType="pmc">PMC8868374</ArticleId><ArticleId IdType="pubmed">35221999</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin R, Yang Y, Chen H, Qin W, Han J, Gu Y, et al. . Prediction of neoadjuvant chemotherapeutic efficacy in patients with locally advanced gastric cancer by serum IgG glycomics profiling. Clin Proteomics (2020) 17:4. doi: 10.1186/s12014-020-9267-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12014-020-9267-8</ArticleId><ArticleId IdType="pmc">PMC7003487</ArticleId><ArticleId IdType="pubmed">32042279</ArticleId></ArticleIdList></Reference><Reference><Citation>Theodoratou E, Tha&#xe7;i K, Agakov F, Timofeeva MN, &#x160;tambuk J, Pu&#x10d;i&#x107;-Bakovi&#x107; M, et al. . Glycosylation of plasma IgG in colorectal cancer prognosis. Sci Rep (2016) 6(1):28098. doi: 10.1038/srep28098</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep28098</ArticleId><ArticleId IdType="pmc">PMC4908421</ArticleId><ArticleId IdType="pubmed">27302279</ArticleId></ArticleIdList></Reference><Reference><Citation>Cvetko A, Kifer D, Gornik O, Klaric L, Visser E, Lauc G, et al. . Glycosylation alterations in multiple sclerosis show increased proinflammatory potential. Biomedicines (2020) 8(10):410. doi: 10.3390/biomedicines8100410</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines8100410</ArticleId><ArticleId IdType="pmc">PMC7599553</ArticleId><ArticleId IdType="pubmed">33065977</ArticleId></ArticleIdList></Reference><Reference><Citation>Adua E, Memarian E, Russell A, Trbojevic-Akmacic I, Gudelj I, Juric J, et al. . High throughput profiling of whole plasma N-glycans in type II diabetes mellitus patients and healthy individuals: A perspective from a Ghanaian population. Arch Biochem Biophys (2019) 661:10&#x2013;21. doi: 10.1016/j.abb.2018.10.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2018.10.015</ArticleId><ArticleId IdType="pubmed">30365935</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin R, Yang Y, Qin W, Han J, Chen H, Zhao J, et al. . The value of serum immunoglobulin G glycome in the preoperative discrimination of peritoneal metastasis from advanced gastric cancer. J Cancer (2019) 10(12):2811&#x2013;21. doi: 10.7150/jca.31380</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/jca.31380</ArticleId><ArticleId IdType="pmc">PMC6584920</ArticleId><ArticleId IdType="pubmed">31258789</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv H, Yang X, Zhou Y, Wu J, Liu H, Wang Y, et al. . Parity and serum lipid levels: a cross-sectional study in chinese female adults. Sci Rep (2016) 6:33831. doi: 10.1038/srep33831</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep33831</ArticleId><ArticleId IdType="pmc">PMC5028753</ArticleId><ArticleId IdType="pubmed">27645134</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi S, Chen Q, Xu D, Xie N, Dai Y. Clinical application of protein biomarkers in lupus erythematosus and lupus nephritis. Lupus (2018) 27(10):1582&#x2013;90. doi: 10.1177/0961203318773643</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203318773643</ArticleId><ArticleId IdType="pubmed">29720035</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. . Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Med (Baltimore) (2003) 82(5):299&#x2013;308. doi: 10.1097/01.md.0000091181.93122.55</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.md.0000091181.93122.55</ArticleId><ArticleId IdType="pubmed">14530779</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Estel GJ, Serrano R, Plasin MA, Espinosa G, Cervera R. Epidemiology and management of refractory lupus nephritis. Autoimmun Rev (2011) 10(11):655&#x2013;63. doi: 10.1016/j.autrev.2011.04.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2011.04.032</ArticleId><ArticleId IdType="pubmed">21565286</ArticleId></ArticleIdList></Reference><Reference><Citation>Lech M, Anders HJ. The pathogenesis of lupus nephritis. J Am Soc Nephrol (2013) 24(9):1357&#x2013;66. doi: 10.1681/ASN.2013010026</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2013010026</ArticleId><ArticleId IdType="pmc">PMC3752952</ArticleId><ArticleId IdType="pubmed">23929771</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan JJ, Jambaldorj E, Lee JG, Jang JY, Shim JM, Han M, et al. . Granulocyte colony-stimulating factor treatment ameliorates lupus nephritis through the expansion of regulatory T cells. BMC Nephrol (2016) 17(1):175. doi: 10.1186/s12882-016-0380-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12882-016-0380-x</ArticleId><ArticleId IdType="pmc">PMC5111287</ArticleId><ArticleId IdType="pubmed">27846813</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottschalk TA, Tsantikos E, Hibbs ML. Pathogenic inflammation and its therapeutic targeting in systemic lupus erythematosus. Front Immunol (2015) 6:550. doi: 10.3389/fimmu.2015.00550</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2015.00550</ArticleId><ArticleId IdType="pmc">PMC4623412</ArticleId><ArticleId IdType="pubmed">26579125</ArticleId></ArticleIdList></Reference><Reference><Citation>Dall&#x2019;Olio F, Vanhooren V, Chen CC, Slagboom PE, Wuhrer M, Franceschi C. N-glycomic biomarkers of biological aging and longevity: a link with inflammaging. Ageing Res Rev (2013) 12(2):685&#x2013;98. doi: 10.1016/j.arr.2012.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2012.02.002</ArticleId><ArticleId IdType="pubmed">22353383</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Yuan H, Lyu J, Meng X, Tian Q, Li Y, et al. . Association of dementia with immunoglobulin G N-glycans in a Chinese Han Population. NPJ Aging Mech Dis (2021) 7(1):3. doi: 10.1038/s41514-021-00055-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41514-021-00055-w</ArticleId><ArticleId IdType="pmc">PMC7862610</ArticleId><ArticleId IdType="pubmed">33542243</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell AC, Simurina M, Garcia MT, Novokmet M, Wang Y, Rudan I, et al. . The N-glycosylation of immunoglobulin G as a novel biomarker of Parkinson&#x2019;s disease. Glycobiology (2017) 27(5):501&#x2013;10. doi: 10.1093/glycob/cwx022</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/glycob/cwx022</ArticleId><ArticleId IdType="pubmed">28334832</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhargava R, Lehoux S, Maeda K, Tsokos MG, Krishfield S, Ellezian L, et al. . Aberrantly glycosylated IgG elicits pathogenic signaling in podocytes and signifies lupus nephritis. JCI Insight (2021) 6(9):e147789. doi: 10.1172/jci.insight.147789</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.147789</ArticleId><ArticleId IdType="pmc">PMC8262331</ArticleId><ArticleId IdType="pubmed">33784256</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrios C, Zierer J, Gudelj I, Stambuk J, Ugrina I, Rodriguez E, et al. . Glycosylation profile of igG in moderate kidney dysfunction. J Am Soc Nephrol (2016) 27(3):933&#x2013;41. doi: 10.1681/ASN.2015010109</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2015010109</ArticleId><ArticleId IdType="pmc">PMC4769202</ArticleId><ArticleId IdType="pubmed">26185202</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao CC, Wang SY, Chuang YK, Lee WY, Chang WC, Wu MS, et al. . Clinical mass spectrometry discovered human igG sialylation as a potential biosignature for kidney function. J Pers Med (2021) 11(8):761. doi: 10.3390/jpm11080761</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm11080761</ArticleId><ArticleId IdType="pmc">PMC8401842</ArticleId><ArticleId IdType="pubmed">34442405</ArticleId></ArticleIdList></Reference><Reference><Citation>Vuckovic F, Kristic J, Gudelj I, Teruel M, Keser T, Pezer M, et al. . Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome. Arthritis Rheumatol (2015) 67(11):2978&#x2013;89. doi: 10.1002/art.39273</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39273</ArticleId><ArticleId IdType="pmc">PMC4626261</ArticleId><ArticleId IdType="pubmed">26200652</ArticleId></ArticleIdList></Reference><Reference><Citation>Karsten CM, Pandey MK, Figge J, Kilchenstein R, Taylor PR, Rosas M, et al. . Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcgammaRIIB and dectin-1. Nat Med (2012) 18(9):1401&#x2013;6. doi: 10.1038/nm.2862</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2862</ArticleId><ArticleId IdType="pmc">PMC3492054</ArticleId><ArticleId IdType="pubmed">22922409</ArticleId></ArticleIdList></Reference><Reference><Citation>Gornik O, Pavic T, Lauc G. Alternative glycosylation modulates function of IgG and other proteins - implications on evolution and disease. Biochim Biophys Acta (2012) 1820(9):1318&#x2013;26. doi: 10.1016/j.bbagen.2011.12.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2011.12.004</ArticleId><ArticleId IdType="pubmed">22183029</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Huang C, Zhou J, Zhao K, Li Y. Causal link between immunoglobulin G glycosylation and cancer: A potential glycobiomarker for early tumor detection. Cell Immunol (2021) 361:104282. doi: 10.1016/j.cellimm.2021.104282</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2021.104282</ArticleId><ArticleId IdType="pubmed">33453507</ArticleId></ArticleIdList></Reference><Reference><Citation>Thurman JM, Yapa R. Complement therapeutics in autoimmune disease. Front Immunol (2019) 10:672. doi: 10.3389/fimmu.2019.00672</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00672</ArticleId><ArticleId IdType="pmc">PMC6456694</ArticleId><ArticleId IdType="pubmed">31001274</ArticleId></ArticleIdList></Reference><Reference><Citation>Park MH, Caselman N, Ulmer S, Weitz IC. Complement-mediated thrombotic microangiopathy associated with lupus nephritis. Blood Adv (2018) 2(16):2090&#x2013;4. doi: 10.1182/bloodadvances.2018019596</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2018019596</ArticleId><ArticleId IdType="pmc">PMC6113612</ArticleId><ArticleId IdType="pubmed">30131343</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinello C, de Haan N, Capitoli G, Trezzi B, Radice A, Pagani L, et al. . Definition of igG subclass-specific glycopatterns in idiopathic membranous nephropathy: aberrant igG glycoforms in blood. Int J Mol Sci (2022) 23(9):4664. doi: 10.3390/ijms23094664</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23094664</ArticleId><ArticleId IdType="pmc">PMC9101794</ArticleId><ArticleId IdType="pubmed">35563055</ArticleId></ArticleIdList></Reference><Reference><Citation>Gornik O, Lauc G. Glycosylation of serum proteins in inflammatory diseases. Dis Markers (2008) 25(4-5):267&#x2013;78. doi: 10.1155/2008/493289</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2008/493289</ArticleId><ArticleId IdType="pmc">PMC3827815</ArticleId><ArticleId IdType="pubmed">19126970</ArticleId></ArticleIdList></Reference><Reference><Citation>Trbojevic AI, Ventham NT, Theodoratou E, Vuckovic F, Kennedy NA, Kristic J, et al. . Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome. Inflammation Bowel Dis (2015) 21(6):1237&#x2013;47. doi: 10.1097/MIB.0000000000000372</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MIB.0000000000000372</ArticleId><ArticleId IdType="pmc">PMC4450892</ArticleId><ArticleId IdType="pubmed">25895110</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Xu X, Huang C, Gao C. N-glycan profiling alterations of serum and immunoglobulin G in immune thrombocytopenia. J Clin Lab Anal (2022) 36(2):e24201. doi: 10.1002/jcla.24201</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.24201</ArticleId><ArticleId IdType="pmc">PMC8842136</ArticleId><ArticleId IdType="pubmed">34957618</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C, Gudelj I, Macdonald-Dunlop E, Mangino M, Zierer J, Besic E, et al. . Glycosylation profile of immunoglobulin G is cross-sectionally associated with cardiovascular disease risk score and subclinical atherosclerosis in two independent cohorts. Circ Res (2018) 122(11):1555&#x2013;64. doi: 10.1161/CIRCRESAHA.117.312174</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.117.312174</ArticleId><ArticleId IdType="pmc">PMC5970566</ArticleId><ArticleId IdType="pubmed">29535164</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi CH, Ruan CP, Wang H, Xu XY, Zhao YP, Fang M, et al. . Function characterization of a glyco-engineered anti-EGFR monoclonal antibody cetuximab in vitro . Acta Pharmacol Sin (2014) 35(11):1439&#x2013;46. doi: 10.1038/aps.2014.77</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2014.77</ArticleId><ArticleId IdType="pmc">PMC4220073</ArticleId><ArticleId IdType="pubmed">25263334</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaytseva OO, Sharapov SZ, Perola M, Esko T, Landini A, Hayward C, et al. . Investigation of the causal relationships between human IgG N-glycosylation and 12 common diseases associated with changes in the IgG N-glycome. Hum Mol Genet (2022) 31(10):1545&#x2013;59. doi: 10.1093/hmg/ddab335</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddab335</ArticleId><ArticleId IdType="pubmed">34791244</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou G, Ochiai H, Huang W, Yang Q, Li C, Wang LX. Chemoenzymatic synthesis and Fcgamma receptor binding of homogeneous glycoforms of antibody Fc domain. Presence of a bisecting sugar moiety enhances the affinity of Fc to FcgammaIIIa receptor. J Am Chem Soc (2011) 133(46):18975&#x2013;91. doi: 10.1021/ja208390n</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja208390n</ArticleId><ArticleId IdType="pmc">PMC3218234</ArticleId><ArticleId IdType="pubmed">22004528</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>